miR-101 suppresses the development of MLL-rearranged acute myeloid leukemia
Estrella Gonzales-Aloy,
Patrick Connerty,
Basit Salik,
Bing Liu,
Andrew J. Woo,
Michelle Haber,
Murray D. Norris,
Jianlong Wang,
Jenny Y. Wang
Affiliations
Estrella Gonzales-Aloy
Cancer and Stem Cell Biology Group, Children’s Cancer Institute, University of New South Wales, Sydney, Australia
Patrick Connerty
Cancer and Stem Cell Biology Group, Children’s Cancer Institute, University of New South Wales, Sydney, Australia
Basit Salik
Cancer and Stem Cell Biology Group, Children’s Cancer Institute, University of New South Wales, Sydney, Australia
Bing Liu
Kids Cancer Alliance, Translational Cancer Research Centre for Kids, Cancer Institute New South Wales, Sydney, Australia
Andrew J. Woo
Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, the University of Western Australia, Crawley, Australia;Centre for Medical Research, The University of Western Australia, Crawley, Australia
Michelle Haber
Children’s Cancer Institute, University of New South Wales, Sydney, Australia
Murray D. Norris
Children’s Cancer Institute, University of New South Wales, Sydney, Australia
Jianlong Wang
Department of Cell, Developmental and Regenerative Biology, Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Jenny Y. Wang
Cancer and Stem Cell Biology Group, Children’s Cancer Institute, University of New South Wales, Sydney, Australia